🇺🇸 FDA
Pipeline program

Macitentan 10 mg tablet, once daily.

2024-KY-0501

Phase 1 small_molecule active

Quick answer

Macitentan 10 mg tablet, once daily. for Coronary Microvascular Angina is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Coronary Microvascular Angina
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials